MATERIAL EVENT4527.TTSE

Rohto Pharmaceutical: change in parent company or specified subsidiary

Summary

ROHTO PHARMACEUTICAL CO., LTD. filed an extraordinary report via EDINET on 2026-01-07 16:05 JST. Reason(s) cited: extraordinary report.

Open the price chart on TradingView.

Source: EDINET S100XEG6 ↗ · PDL1.0 · Not investment advice